Musk testimony dominated first week Musk v. Altman. 'You can't just steal a charity'

Elon Musk’s OpenAI lawsuit entered its first week in a federal trial centered on allegations that OpenAI and its leaders abandoned the nonprofit mission and misused roughly $38 million in donations for commercial purposes. Musk is seeking up to $134 billion in damages, removal of Sam Altman and Greg Brockman, and a unwind of OpenAI’s for-profit restructuring, while OpenAI calls the claims baseless. The case also highlights OpenAI’s $850 billion private valuation and Musk’s competing xAI business, which he says has partly used OpenAI technology to train its models.

Analysis

This trial is less about legal liability than about who gets to own the narrative premium on frontier AI. If the court even partially validates the idea that OpenAI’s governance transition was improper, the immediate beneficiary is not Musk so much as any incumbent with a cleaner corporate structure and lower headline risk, while OpenAI’s ability to recruit talent, close enterprise deals, and raise at ever-higher marks gets a modest discount. The real second-order effect is on Microsoft: the market has been willing to underwrite OpenAI through a partnership lens, but litigation that keeps questioning the company’s constitutional structure raises the probability of deal friction, disclosure overhang, and slower monetization of the embedded option value.

The bigger risk is timing. Near-term, this is a volatility catalyst for AI names rather than a fundamentals event; legal outcomes will unfold over months, but the market will trade every witness as a referendum on governance quality. If investors start assigning even a small probability that the for-profit conversion is partially unwound, the implied duration of OpenAI cash flows extends, which is negative for the multiple stack across AI-adjacent software, infrastructure, and Microsoft’s strategic equity value.

Google is the quiet relative winner in a world where the open question becomes not whether AI is large, but which institution can be trusted to build it. A prolonged courtroom narrative around “mission drift” should help Google’s messaging around responsible AI, even if it does not translate into immediate share gains. The contrarian miss is that Musk’s own competing exposure creates a symmetry problem: every argument he makes against commercialization also highlights that xAI is being valued on the very same market enthusiasm he is attacking, so the trial may ultimately compress the valuation gap between the whole cohort rather than rerate one side dramatically.

Key Decisions for Investors

• Buy short-dated MSFT downside protection: 1-3 month puts or put spreads into each major testimony date; the thesis is not earnings damage but multiple compression from governance overhang if the judge signals receptivity to plaintiff arguments.
• Relative-value pair: long GOOGL / short MSFT for the next 4-8 weeks; if the market re-prices AI as a governance contest, Google’s lower legal entanglement and cleaner narrative should outperform on a risk-adjusted basis.
• Avoid fresh long exposure to private AI infrastructure names with OpenAI dependency until the liability phase concludes; the best entry is after the May 21 window if no adverse procedural ruling emerges.
• For TSLA holders, treat this as a distraction rally risk rather than a stock-specific catalyst; consider overwriting upside with 30-60 day covered calls to monetize elevated event volatility while preserving core exposure.
• If OpenAI-related headlines intensify, add to a basket short of high-multiple AI software proxies versus long semis/infrastructure, since legal uncertainty hurts application-layer multiples more than compute suppliers.